§ Funding Round
Series C funding round for Monte Rosa Therapeutics raising $95M in March 2021
Series C funding round for Monte Rosa Therapeutics raising $95M in March 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Amzak Health Investors | — | — |
EQT Life Sciences | — | — |
| Organization | — | |
| Angel | ali behbahani | |
New Enterprise Associates | — | — |
| Organization | — | |
| Angel | andrew schiff | |
behzad aghazadehLEAD | Angel | behzad aghazadeh |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Fidelity Management & Research Company | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
T. Rowe Price Associates | — | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$224M
Top Valuation
-
Monte Rosa Therapeutics raised $95M in a Series C round.
The round was announced on 03/01/21.
The round was led by behzad aghazadeh.
